Intravenous calcium and magnesium prevents oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: Results of a phase III placebo-controlled,
Supporting the Needs of Human Subjects in Research Carol Johnston, Chair, Bioscience IRB Mark Roosa, Chair, Social Behavioral IRB.
“Fighting Cancer: It’s All We Do.” ™
OFEV ® (nintedanib) INPULSIS ® trial design and baseline characteristics Last updated 08.09.2015 These slides are provided by Boehringer Ingelheim for.
Intravenous Calcium and Magnesium (CaMg) Reduces Chronic, But Not Acute Neurotoxicity Associated With Oxaliplatin – Results From a Placebo- controlled.
Randomized, double-blind, placebo- controlled phase 2 study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian carcinoma Beth.
PTK/ZK: An Oral Multi-VEGF Receptor Inhibitor
Journal Club
XOMA
Conflict of Interest
